BiotechTubeBiotechTube
Home/Avalon GloboCare/Meng Li
ML

Meng Li

Interim Chief Executive Officer and Chief Operating Officer

Avalon GloboCare

Therapeutic Areas

Metabolic HealthInflammatory DiseasesImmune Conditions

Avalon GloboCare Pipeline

DrugIndicationPhase
KetoAir™ BreathalyzerKetosis Monitoring / Metabolic HealthCommercial
QTY Code Cytokine Receptors (Six Variants)Inflammatory & Immune Conditions (Research Platform)Pre-clinical

Leadership Team at Avalon GloboCare

LI
Luisa Ingargiola
Chief Financial Officer
WL
Wenzhao Lu
Chairman of the Board
MM
Michael Mathews
Director
SS
Steven Sanders, Esq.
Lead Independent Director
LF
Lourdes Felix
Director
SZ
Shuguang Zhang
Principal Investigator (MIT Collaborator for QTY Code Platform)
View full Avalon GloboCare profile